Myopotential sensing by a dual chamber implantable cardioverter defibrillator: Two case reports

被引:22
作者
Deshmukh, P [1 ]
Anderson, K [1 ]
机构
[1] Robert Packer Hosp, Arrhythmia Ctr, Div Cardiol, Sayre, PA 18840 USA
关键词
implantable cardioverter defibrillator; oversensing; myopotentials;
D O I
10.1111/j.1540-8167.1998.tb00964.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Inappropriate discharges and/or improper inhibition of bradycardia pacing due to oversensing of estraneous signals in implantable cardioverter defibrillators (ICDs) have been described, With one exception, no previous report involving an intact lead system has cited myopotential oversensing as the cause, Methods and Results: Two case reports of myopotential oversensing by a dual chamber ICD system are reported, In the first patient suffering from chronic pulmonary obstructive disease, intermittent myopotential sensing during labored respiration resulted in episodic inhibition of bradycardia pacing, In the second patient, oversensing of sustained myopotentials generated during strenuous isometric activity resulted in an inappropriate ICD discharge, For both, the ICD system consisted of a CPI model 1810 Ventak AV used in conjunction with a model 0125 Endotak lead, incorporating integrated bipolar sensing, Conclusion: Although modern ICDs have proven to be highly effective in detecting and terminating malignant tachyarrhythmias, the opportunity for improving their detection specificity remains.
引用
收藏
页码:767 / 772
页数:6
相关论文
共 19 条
[1]   CLINICAL-EXPERIENCE WITH A TIERED-THERAPY, MULTIPROGRAMMABLE ANTIARRHYTHMIA DEVICE [J].
BARDY, GH ;
TROUTMAN, C ;
POOLE, JE ;
KUDENCHUK, PJ ;
DOLACK, GL ;
JOHNSON, G ;
HOFER, B .
CIRCULATION, 1992, 85 (05) :1689-1698
[2]   INHIBITION OF BIPOLAR DEMAND PACEMAKER BY DIAPHRAGMATIC MYOPOTENTIALS [J].
BAROLD, SS ;
ONG, LS ;
FALKOFF, MD ;
HEINLE, RA .
CIRCULATION, 1977, 56 (04) :679-683
[3]   Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature [J].
Curwin, JH ;
Roelke, M ;
Ruskin, JN .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (01) :124-126
[4]   THE CLINICAL INCIDENCE AND SIGNIFICANCE OF MYOPOTENTIAL SENSING WITH UNIPOLAR PACEMAKERS [J].
FETTER, J ;
BOBELDYK, GL ;
ENGMAN, FJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1984, 7 (05) :871-881
[5]   PACEMAKER INHIBITION BY MYOPOTENTIALS ASSOCIATED WITH MOTION AND EXERCISE [J].
GIALAFOS, J ;
MAILLIS, A ;
KANDILAS, J .
EUROPEAN HEART JOURNAL, 1987, 8 :149-154
[6]   THE CLINICAL RELEVANCE OF ELECTROMYOPOTENTIAL OVERSENSING IN CURRENT UNIPOLAR DEVICES [J].
GROSS, JN ;
PLATT, S ;
RITACCO, R ;
ANDREWS, C ;
FURMAN, S .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (11) :2023-2027
[7]  
ITO H, 1987, JPN HEART J, V28, P157
[8]   OVERSENSING DURING VENTRICULAR PACING IN PATIENTS WITH A 3RD-GENERATION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR [J].
KELLY, PA ;
MANN, DE ;
DAMLE, RS ;
REITER, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (07) :1531-1534
[9]  
McAnulty J, 1997, NEW ENGL J MED, V337, P1576
[10]  
NEUZNER J, 1997, PACE 2, V20, P1225